An immunohistological study of anhydrous topical ascorbic acid compositions on ex vivo human skin

Journal of Cosmetic Dermatology

Volumn 5, Issue 2, 2006, Pages 150-156

  Heber, Geoffrey K ^a   Markovic, Boban ^b   Hayes, Amanda ^b  

^a Heber Davis   (Australia)

^b NONE

Author keywords

Ascorbic acid; Collagen; Topical therapeutic

Indexed keywords

ASCORBIC ACID; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKERATIN; DRUG VEHICLE; MONOCLONAL ANTIBODY; NANOPARTICLE; OIL; SILICONE; WAX;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL COMPOSITION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DRUG EXPOSURE; DRUG FORMULATION; DRUG MECHANISM; DRUG STABILITY; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IONIZATION; MICROSCOPY; OXIDATION; PHOTOAGING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RATING SCALE; TIME; TISSUE SECTION;

ABDOMEN; ADMINISTRATION, TOPICAL; ANTIOXIDANTS; ASCORBIC ACID; CHEMISTRY, PHARMACEUTICAL; COLLAGEN TYPE I; COLLAGEN TYPE III; HUMANS; KERATINS; NANOPARTICLES; SKIN; SKIN ABSORPTION; TISSUE CULTURE TECHNIQUES; VEHICLES;

EID: 33745276805     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2006.00242.x     Document Type: Article

References (36)

1. Geesin JC, Darr D, Kaufman R, Murad S, Pinnell SR. Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast. J Invest Dermatol 1988; 90 (4): 420-4.
2. Murad S, Grove D, Lindberg KA, Reynolds G, Sivarajah A, Pinnell SR. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci USA 1981; 78 (5): 2879-82.
3. Nusgens BV, Humbert P, Rougier A et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol 2001; 116 (6): 853-9.
4. Murad S, Sivarajah A, Pinnell SR. Regulation of prolyl and lysyl hydroxylase activities in cultured human skin fibroblasts by ascorbic acid. Biochem Biophys Res Commun 1981; 101 (3): 868-75.
5. Darr D, Dunston S, Faust H, Pinnell S. Effectiveness of antioxidants (vitamins C and E) with and without sunscreens as topical photoprotectants. Acta Derm Venereol 1996; 76 (4): 264-8.
6. Lin JY, Selim MA, Shea CR et al. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol 2003; 48 (6): 866-74.
7. Fujiwara Y, Sahashi Y, Aritro M et al. Effect of simultaneous administration of vitamin C, L-cysteine and vitamin E on the melanogenesis. Biofactors 2004; 21 (1-4): 415-8.
8. Quevedo WC Jr, Holstein TJ, Dyckman J, McDonald CJ, Isaacson EL. Inhibition of UVR-induced tanning and immunosuppression by topical applications of vitamins C and E to the skin of hairless (hr/hr) mice. Pigment Cell Res 2000; 13 (2): 89-98.
9. Regnier M, Tremblaye C, Schmidt R. Vitamin C affects melanocyte dendricity via keratinocytes. Pigment Cell Res 2005; 18 (5): 389-90.
10. Ponec M, Weerheim A, Kempenaar J et al. The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol 1997; 109 (3): 348-55.
11. Uchida Y, Behne M, Quiec D, Elias PM, Holleran WM. Vitamin C stimulates sphingolipid production and markers of barrier formation in submerged human keratinocyte cultures. J Invest Dermatol 2001; 117 (5): 1307-13.
12. Pasonen-Seppanen S, Suhonen TM, Kirjavainen M et al. Vitamin C enhances differentiation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier. Histochem Cell Biol 2001; 116 (4): 287-97.
13. Ashino H, Shimamura M, Nakajima H et al. Novel function of ascorbic acid as an angiostatic factor. Angiogenesis 2003; 6 (4): 259-69.
14. Gottschalck TE, McEwen GN Jr, eds. International Cosmetic Ingredient Dictionary and Handbook, 10th edn, Vol. 1. The Cosmetic Toiletry and Fragrance Association; 2004: P. 146.
15. O'Neil MJ, Smith A, Heckelman PE, eds. The Merck Index, 13rd edn. Washington, DC: Merck & Co., Inc; 2001: p. 141.
16. Merriam-Webster Online Dictionary. Springfield, IN: Merriam-Webster, Inc., 2005.
17. Compact Oxford English Dictionary. Oxford: Oxford University Press, 2005.
18. Austria R, Semenzato A, Bettero A. Stability of vitamin C derivatives in solution and topical formulations. J Pharm Biomed Anal 1997; 15 (6): 795-801.
19. Gallarate M. Carlotti ME, Trotta M, Bovo S. On the stability of ascorbic acid in emulsified systems for topical and cosmetic use. Int J Pharm 1999: 188 (2): 233-41.
20. Gallarate M, Carlotti ME, Trotta M, Bovo S. On the stability of ascorbic acid in emulsified systems for topical and cosmetic use. Int J Pharm 1999; 188 (2): 233-41.
21. Lee JS, Kim JW, Han SH et al. The stabilization of L-ascorbic acid in aqueous solution and water-in-oil-in-water double emulsion by controlling pH and electrolyte concentration. J Cosmet Sci 2004; 55 (1): 1-12.
22. Fujinami Y, Tai A, Yamamoto I. Radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl of ascorbic acid 2-glucoside (AA-2G) and 6-acyl-AA-2G. Chem Pharm Bull (Tokyo) 2001; 49 (5): 642-4.
23. Kobayashi S, Takehana M, Itoh S, Ogata E. Protective effect of magnesium-L-ascorbyl-2 phosphate against skin damage induced by UVB irradiation. Photochem Photobiol 1996; 64 (1): 224-8.
24. Pinnell SR, Yang H, Omar M et al. Topical L-ascorbic acid: Percutaneous absorption studies. Dermatol Surg 2001; 27 (2): 137-42.
25. Geesin JC, Gordon JS, Berg RA. Regulation of collagen synthesis in human dermal fibroblasts by the sodium and magnesium salts of ascorbyl-2-phosphate. Skin Pharmacol 1993; 6 (1): 65-71.
26. Raschke T, Koop U, Dusing HJ et al. Topical activity of ascorbic acid: from in vitro optimization to in vivo efficacy. Skin Pharmacol Physiol 2004; 17 (4): 200-6.
27. Taylor RM, Wilson DJ. Ascorbic acid composition and transdermal administration method. United States Patent 5,308,621 and related patents 1994.
28. Diembeck W, Beck H, Benech-Kieffer F et al. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic, Toiletry and Perfumery Association. Food Chem Toxicol 1999; 37 (2-3): 191-205.
29. Walters KA, Brain KR, Dressler WE et al. Percutaneous penetration of nitroso-N-methyldodecylamine through human skin in vitro: Application from cosmetic vehicles. Food Chem Toxicol 1997; 35 (7): 705-12.
30. Hayes AJ, Markovic B. Alternatives to animal testing for determining the safety of cosmetics. Cosmet Aerosols Toiletries Aust 1999; 5: 24-30.
31. Hayes AJ, Markovic B. Toxicity of Australian essential oil Backhousia citriodora (lemon myrtle). Part 2. Absorption and histopathology following application to human skin. Food Chem Toxicol 2003; 41 (10): 1409-16.
32. Markovic B, Wu ZH, Chesterman CN, Chong BH. Quantitation of Fc gamma RII mRNA in platelets and megakaryoblastic cell lines by a new method of in situ hybridization. J Immunol Methods 1994; 172 (1): 105-14.
33. Ademola JI, Chow CA, Wester RC, Maibach HI. Metabolism of propranolol during percutaneous absorption in human skin. J Pharm Sci 1993; 82 (8): 767-70.
34. Garnett A, Hotchkiss SA, Caldwell J. Percutaneous absorption of benzyl acetate through rat skin in vitro. Part 3. A comparison with human skin. Food Chem Toxicol 1994; 32 (11): 1061-5.
35. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 2004; 123 (1): 168-76.
36. Rolland A, Wagner N, Chatelus A, Shroot B, Schaefer H. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res 1993; 10 (12): 1738-44.